X
Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
I UNDERSTAND
English Section

EU strikes COVID-19 vaccine deal with CureVac

17.11.2020 01:00
The European Union's executive is on Tuesday expected to authorize a deal with German biotech firm CureVac to secure up to 405 million doses of its potential COVID-19 vaccine, news agencies have reported.
European Commission President Ursula von der Leyen gives a press conference in Brussels, Belgium, on Monday, Nov. 16, 2020.
European Commission President Ursula von der Leyen gives a press conference in Brussels, Belgium, on Monday, Nov. 16, 2020.Photo: PAP/EPA/KENZO TRIBOUILLARD/POOL

The deal comes after the head of the European Commission, Ursula von der Leyen, announced the plan to the media on Monday.

"The coronavirus continues to spread rapidly across Europe," she said at a news conference. "We need a safe and effective vaccine to end this pandemic."

She added: "A few days after our contract with BioNTech and Pfizer, I am happy to announce a new agreement. Tomorrow, we will authorise a new contract to secure another COVID-19 vaccine for Europeans. This contract allows us to buy up to 405 million doses of a vaccine produced by the European company CureVac."

Von der Leyen also said that the contract with CureVac follows EU funding to the German company to help develop its vaccine.

The latest deal with CureVac follows agreements the European Commission previously reached with AstraZeneca, Johnson & Johnson, Sanofi, and Pfizer for the supply of their potential vaccines, the Reuters news agency reported.

Von der Leyen also told reporters she hoped to finalize a deal soon with US drug maker Moderna for its COVID-19 vaccine, Poland’s PAP news agency reported.

Moderna announced on Monday that its experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage trial.

(gs)

Source: PAP, Reuters, ec.europa.eu